Researchers at the University of Toronto have found that Omicron variants of the COVID-19-causing virus can be hindered in their ability to infect people by mutations in the spike protein that prevent the virus from binding to and entering cells.
SARS-CoV-2 B.1.1.529 (Omicron) Variant — United States, December 1
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody
Donnelly Centre for Cellular & Biomolecular Research
What is a variant? An expert explains, News
Temerty Faculty of Medicine
The Omicron variant is highly resistant against antibody-mediated
Omicron and Other Coronavirus Variants: What You Need to Know
SARS-CoV-2 RBD vulnerability discovered - target for antibodies
Mechanisms of SARS-CoV-2 entry into cells
Medical Research University of Toronto
Temerty Faculty of Medicine
SARS-CoV-2 variants, spike mutations and immune escape
Rapid evaluation of COVID-19 vaccine effectiveness against
COVID-19 University of Toronto